Co spent many money to development of Vimizim, analysts say it will triple revenue, CEO and co have a lot of confidence about it. if you analyze the previous earnings they never realized exceptional results in the previous quarter, and then? Shares have risen all the same because it depends on the findings on new molecules to treat complex diseases! Co deals with orphan drugs, not to sell merchandise or car! The resources invested will return in if the drug Vimizim may be approved by the FDA! this is my reasoning, of course, I'll carefully read the thoughts of analysts that ll surely come out in the next few days. Surely there will be speculation on the news of this latest ER but on balance it never looks at the impact on YTD
Reports Q3 (Sep) GAAP loss of $0.38 per share, $0.08 worse than the Capital IQ Consensus Estimate of ($0.30); revenues rose 6.9% year/year to $136.9 mln vs the $139.86 mln consensus.
Naglazyme net product revs rose 1.1% yoy to $63.2 mln
Aldurazyme royalty revs declined 1.7% yoy to $23.4 mln
Kuvan revs rose 19.8% yoy to $43.6 mln
You said approved meds are on decline, based on what? look this!
"The next major inflection point for the company is the potential market approval of Vimizim in the U.S. and Europe. We have been working diligently to prepare for the launch of this drug and look forward to the Advisory Committee meeting November 19 and potential CHMP opinion, which we expect near the end of the year or early 2014."
Co reaffirms guidance for FY13, sees FY13 revs of $530-555 mln vs. $550.97 mln Capital IQ Consensus Estimate.
tomorrow we'll see what shareholders will do. Atm zero movements on AH
Micron Technology: A Buying Opportunity After Recent Earnings http://seekingalpha.com/f/a/11tom $MU
hot upcoming events
Nov 20, 2013
Micron Technology, Inc. at Daiwa Investment Conference Hong Kong Add to calendar
Nov 19, 2013
Micron Technology, Inc. at JPMorgan Global Technology, Media & Telecom Conference Add to calendar
Nov 19, 2013
Micron Technology, Inc. at UBS Global Technology Conference Add to calendar
Nov 14, 2013
Micron Technology, Inc. at Morgan Stanley Asia Pacific Summit Add to calendar
Nov 13, 2013
Micron Technology, Inc. at RBC Capital Markets Technology, Media & Telecommunications Conference Add to calendar
Nov 12, 2013
Micron Technology, Inc. at Wells Fargo Technology, Media & Telecom Conference Add to calendar
Nov 6, 2013
Micron Technology, Inc. at Needham HDD/Flash Memory & Systems Conference - 8:00AM EST -
they are going face earning missunderstandinng w analysts!
3rd memory dev. of the world, tp are still so far, solid balance and good future prosp., why should I sell?
Feuerstein skewers Catalyst, says Firdapse equivalent offered for free. Maybe this one, discuss!
Micron falls as confusion surrounds 4Q results (AP on Yahoo Finance)